Avantor, Inc. (NYSE:AVTR) reported its Q4 2025 earnings, missing EPS expectations. The company is undergoing a “Revival” program, reorganizing into two new business units: VWR distribution and services, and bioscience and medtech products, to sharpen strategic focus and improve execution. Avantor anticipates 2026 to be a year of transition and investment, with expected organic revenue growth of -2.5% to -0.5% and adjusted EPS of 77¢ to 83¢.
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
Avantor, Inc. (NYSE:AVTR) Q4 2025 Earnings Call Transcript
Avantor, Inc. (NYSE:AVTR) reported its Q4 2025 earnings, missing EPS expectations. The company is undergoing a “Revival” program, reorganizing into two new business units: VWR distribution and services, and bioscience and medtech products, to sharpen strategic focus and improve execution. Avantor anticipates 2026 to be a year of transition and investment, with expected organic revenue growth of -2.5% to -0.5% and adjusted EPS of 77¢ to 83¢.